LBF20207OX01: Difference between revisions
No edit summary |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 6: | Line 6: | ||
|LipidBank=DFA8155 | |LipidBank=DFA8155 | ||
|LipidMaps=LMFA01060073 | |LipidMaps=LMFA01060073 | ||
|SysName=15- | |SysName=15-Oxo- (cis-11,trans-13) -eicosadienoic acid | ||
|Common Name=&&15- | |Common Name=&&15-Oxo-(11Z,13E) -eicosadienoic acid&& | ||
|UV Spectra= lambda max: 279nm epsilon : 23,000 | |UV Spectra= lambda max: 279nm epsilon : 23,000 | ||
|Source= | |Source= | ||
Latest revision as of 07:30, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8155 |
| LipidMaps | LMFA01060073 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207OX01 |
| 15-Oxo-(11Z,13E) -eicosadienoic acid | |
|---|---|
| |
| Structural Information | |
| 15-Oxo- (cis-11,trans-13) -eicosadienoic acid | |
| |
| 15-OxoEDE/15-KEDE | |
| Formula | C20H34O3 |
| Exact Mass | 322.25079495399996 |
| Average Mass | 322.48216 |
| SMILES | C(CCC(C=CC=CCCCCCCCCCC(O)=O)=O)CC |
| Physicochemical Information | |
| 15-OxoEDE is produced by the oxidation of 15-HEDE. Some other oxo-eicosanoids have been shown to be biosynthesized and to have potent inflammatory activity Powell_WS et al.. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | λ max: 279nm ε : 23,000 |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
